WORLD PEPTIDEFOUNDATION
← Master Registry

Published peptide research references

DOTATATE

Governed registry record

3 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.

Approved source records

  1. (177)Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors.

    DOI: 10.1080/17474124.2019.1685381

    Source identity and connection checked by Codex (AI).

  2. (177)Lu-Dotatate plus long-acting octreotide versus high‑dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial.

    DOI: 10.1016/s1470-2045(21)00572-6

    Source identity and connection checked by Codex (AI).

  3. Phase 3 Trial of (177)Lu-Dotatate for Midgut Neuroendocrine Tumors.

    DOI: 10.1056/nejmoa1607427

    Source identity and connection checked by Codex (AI).

Legacy research context

Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.

Researchers represented

  • Das S
  • Al-Toubah T
  • El-Haddad G
  • Strosberg J
  • Strosberg JR
  • Caplin ME
  • Kunz PL
  • Ruszniewski PB
  • Bodei L
  • Hendifar A
  • Mittra E
  • Wolin EM
  • Yao JC
  • Pavel ME
  • Grande E
  • Van Cutsem E
  • Seregni E
  • Duarte H
  • Gericke G
  • Bartalotta A
  • Mariani MF
  • Demange A
  • Mutevelic S
  • Krenning EP
  • NETTER-1 investigators
  • Wolin E
  • Yao J
  • Chasen B
  • Kulke MH
  • Jacene H
  • Bushnell D
  • O'Dorisio TM
  • Baum RP
  • Kulkarni HR
  • Caplin M
  • Lebtahi R
  • Hobday T
  • Delpassand E
  • Benson A
  • Srirajaskanthan R
  • Pavel M
  • Mora J
  • Berlin J
  • Reed N
  • Öberg K
  • Lopera Sierra M
  • Santoro P
  • Thevenet T
  • Erion JL
  • Ruszniewski P
  • Kwekkeboom D
  • Krenning E
  • NETTER-1 Trial Investigators
  • Singh S
  • Halperin D
  • Myrehaug S
  • Herrmann K
  • Tafuto S
  • Lastoria S
  • Capdevila J
  • García-Burillo A
  • Oh DY
  • Yoo C
  • Halfdanarson TR
  • Falk S
  • Folitar I
  • Zhang Y
  • Aimone P
  • de Herder WW
  • Ferone D
  • all the NETTER-2 Trial Investigators